Forward Citations = 74

Loading Chart...

4 inventors (with patents filed for the assignee):

D Scott Wilbur (5 out of 13 patents)

A Charles Morgan, Jr (5 out of 15 patents)

Pradip M Pathare (3 out of 6 patents)

4. Alton C Morgan, Jr (1 out of 9 patents)

6 patents: Sort by Forward Citations

1. 6083926 - Water soluble vitamin B.sub.12 receptor modulating agents and methods (2000-07-04),

2. 5869465 - Methods of receptor modulation and uses therefor (1999-02-09),

3. 5840880 - Receptor modulating agents (1998-11-24),

4. 5840712 - Water soluble vitamin B.sub.12 receptor modulating agents and methods (1998-11-24),

5. 5739287 - Biotinylated cobalamins (1998-04-14),

6. 5688504 - Anti-receptor and growth blocking antibodies to the vitamin B.sub.12 (1997-11-18),

Receptagen Corporation is a biotechnology company specializing in the development of innovative therapeutic solutions for various diseases. With a focus on cutting-edge research and development, Receptagen is dedicated to improving patient outcomes and quality of life. The company's portfolio includes novel drug candidates targeting cancer, autoimmune disorders, and infectious diseases.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

6 Patents

#3 in Edmonds, WA

#1,009 in Washington

#43,751 in US

Edmonds, WA, United States of America

Receptagen Corporation

Forward Citations = 74

4 inventors:

D Scott Wilbur (5 out of 13 patents)

A Charles Morgan, Jr (5 out of 15 patents)

Pradip M Pathare (3 out of 6 patents)

4. Alton C Morgan, Jr (1 out of 9 patents)

Please report any incorrect information to support@idiyas.com